Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20061026rdf:typepubmed:Citationlld:pubmed
pubmed-article:20061026lifeskim:mentionsumls-concept:C0023281lld:lifeskim
pubmed-article:20061026lifeskim:mentionsumls-concept:C0012984lld:lifeskim
pubmed-article:20061026lifeskim:mentionsumls-concept:C0024432lld:lifeskim
pubmed-article:20061026lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:20061026lifeskim:mentionsumls-concept:C0085732lld:lifeskim
pubmed-article:20061026lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:20061026lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:20061026lifeskim:mentionsumls-concept:C0162388lld:lifeskim
pubmed-article:20061026lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:20061026lifeskim:mentionsumls-concept:C1522673lld:lifeskim
pubmed-article:20061026pubmed:issue2lld:pubmed
pubmed-article:20061026pubmed:dateCreated2010-2-17lld:pubmed
pubmed-article:20061026pubmed:abstractTextThe aim of this study was to evaluate, in terms of dog macrophage killing ability in vitro, a vaccine based on Leishmania infantum promastigote soluble antigen (LSA) formulated with three different adjuvants (BCG, AdjuPrime, MPL/TDM/CWS). A significant increase of the macrophage killing ability was observed in dogs vaccinated with LSA+MPL/TDM/CWS after 1 month from vaccination. A similar increase of macrophage parasitocidal ability was present only after 5 months in dogs vaccinated with LSA+BCG or LSA+AdjuPrime. In all dogs the augmented killing percentage was still present after 12 months from vaccination. Therefore, in particular LSA+MPL/TDM/CWS vaccine seems promising for further studies in dogs.lld:pubmed
pubmed-article:20061026pubmed:languageenglld:pubmed
pubmed-article:20061026pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061026pubmed:citationSubsetIMlld:pubmed
pubmed-article:20061026pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061026pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061026pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061026pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061026pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061026pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061026pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061026pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061026pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061026pubmed:statusMEDLINElld:pubmed
pubmed-article:20061026pubmed:monthMarlld:pubmed
pubmed-article:20061026pubmed:issn1878-1667lld:pubmed
pubmed-article:20061026pubmed:authorpubmed-author:BrandonisioOOlld:pubmed
pubmed-article:20061026pubmed:authorpubmed-author:MitoloVVlld:pubmed
pubmed-article:20061026pubmed:authorpubmed-author:GradoniLLlld:pubmed
pubmed-article:20061026pubmed:authorpubmed-author:AcquafreddaAAlld:pubmed
pubmed-article:20061026pubmed:authorpubmed-author:FasanellaAAlld:pubmed
pubmed-article:20061026pubmed:authorpubmed-author:PanaroM AMAlld:pubmed
pubmed-article:20061026pubmed:authorpubmed-author:TrottaTTlld:pubmed
pubmed-article:20061026pubmed:authorpubmed-author:ScaltritoDDlld:pubmed
pubmed-article:20061026pubmed:copyrightInfo2009 Elsevier Ltd. All rights reserved.lld:pubmed
pubmed-article:20061026pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20061026pubmed:volume33lld:pubmed
pubmed-article:20061026pubmed:ownerNLMlld:pubmed
pubmed-article:20061026pubmed:authorsCompleteYlld:pubmed
pubmed-article:20061026pubmed:pagination175-82lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:meshHeadingpubmed-meshheading:20061026...lld:pubmed
pubmed-article:20061026pubmed:year2010lld:pubmed
pubmed-article:20061026pubmed:articleTitleComparison between three adjuvants for a vaccine against canine leishmaniasis: In vitro evaluation of macrophage killing ability.lld:pubmed
pubmed-article:20061026pubmed:affiliationDipartimento di Scienze Biomediche, University of Foggia, Ospedali Riuniti, Italy. t.trotta@unifg.itlld:pubmed
pubmed-article:20061026pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20061026pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:20061026pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:20061026pubmed:publicationTypeClinical Trial, Phase Illd:pubmed